Clinical Report: Robotic-assisted techniques in percutaneous coronary intervention
Overview
Robotic-assisted percutaneous coronary intervention (rPCI) offers an alternative to manual PCI (mPCI) by reducing occupational radiation exposure for operators while maintaining procedural success. Various rPCI platforms have been developed, demonstrating high clinical success rates and reductions in radiation exposure.
Background
Percutaneous coronary intervention (PCI) is a critical procedure for managing coronary artery disease (CAD), particularly in acute and chronic syndromes. Manual PCI is associated with occupational hazards, including radiation exposure and musculoskeletal disorders for operators. Robotic-assisted techniques aim to mitigate these risks while ensuring effective patient outcomes.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
Robotic-assisted PCI (rPCI) allows for device manipulation from a remote workstation, reducing operator radiation exposure.
The first-generation CorPath 200 system demonstrated a 97.6% clinical success rate in the PRECISE study.
Median radiation exposure for primary operators was reduced by 95.2% with the CorPath 200 system.
Recent trials indicate that rPCI is safe and effective for selected lesions, with non-inferiority to manual PCI.
Robotic systems may improve ergonomics for operators.
Clinical Implications
The implementation of rPCI could enhance operator safety by minimizing radiation exposure during procedures. As rPCI technology continues to evolve, it may provide a viable option for treating patients with coronary artery disease, particularly in complex cases.
Conclusion
Robotic-assisted techniques in PCI represent a significant advancement in interventional cardiology, potentially improving safety for operators while maintaining high procedural success rates.
An interpretable machine-learning model classified angiographic coronary artery disease in patients referred for coronary angiography, but high disease prevalence and unclear inflammatory signals limited clinical interpretation.
